Clinical Trials Directory

Trials / Sponsors / Sagimet Biosciences Inc.

Sagimet Biosciences Inc.

Industry · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
CompletedA Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants
Healthy
Phase 12025-09-30
RecruitingPhase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Wit
Acne
Phase 12025-06-03
WithdrawnA Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis
MASH, NASH, Metabolic Dysfunction-associated Steatohepatitis
Phase 32025-03-01
WithdrawnA Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH
MASLD, MASH, NASH
Phase 32025-03-01
CompletedA Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic I
Non-alcoholic Steatohepatitis, Hepatic Impairment, Cirrhosis
Phase 12023-05-01
CompletedOpen-label Study of the Absorption, Metabolism, and Excretion of [14C]TVB-2640 Following a Single Oral Dose in
Healthy Volunteers
Phase 12022-11-21
CompletedStudy of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
Phase 22021-08-12
CompletedStudy of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Phase 22019-03-22
CompletedA Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors
Solid Malignant Tumor
Phase 12013-11-01